/ORTI-B.ST
ORTI-B.ST Stock - Ortivus AB (publ)
Healthcare|Medical - Instruments & SuppliesSTO
$1.21-0.82%
$0.01 (-0.82%) • Dec 23
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.44
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.94
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.33
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ORTI-B.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.20 – $1.22
TARGET (TP)$1.39
STOP LOSS$1.11
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.65
52W High$1.90
52W Low$0.80
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $80.41M | $84.08M | $104.51M | $94.27M | $107.58M |
| Gross Profit | $27.93M | $30.84M | $48.72M | $47.87M | $38.95M |
| Gross Margin | 34.7% | 36.7% | 46.6% | 50.8% | 36.2% |
| Operating Income | $-19,532,000 | $-17,612,000 | $5.85M | $9.35M | $11.39M |
| Net Income | $-24,903,000 | $-18,245,000 | $5.89M | $9.21M | $11.33M |
| Net Margin | -31.0% | -21.7% | 5.6% | 9.8% | 10.5% |
| EPS | $-0.56 | $-0.41 | $0.13 | $0.21 | $0.26 |
Company Overview
Ortivus AB (publ) develops and commercializes medical technology solutions for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitors and measures the patient's vital parameters, such as ECG, blood pressure, and SpO2; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed Life, which is designed for advanced monitoring and resuscitation; and MobiMed Cloud that supports multiplatform data sharing on Windows, Webb, IOS, and Android. It also provides support, implementation, training, and consulting services. The company was incorporated in 1985 and is headquartered in Danderyd, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ORTI-B.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.22
Q4 2024
EPS Surprise History
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Dec 31, 2024 | — | $-0.22 | — | — |
Q3 2024 | Sep 30, 2024 | — | $-0.10 | — | — |
Q2 2024 | Jun 29, 2024 | — | $-0.19 | — | — |
Q1 2024 | Mar 30, 2024 | — | $-0.05 | — | — |
Q4 2023 | Dec 30, 2023 | — | $-0.06 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.25 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.11 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.00 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.01 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.08 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.04 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.04 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.06 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.07 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.04 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.05 | — | — |
Q3 2020 | Sep 30, 2020 | — | $0.03 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.15 | — | — |
Q1 2020 | Mar 31, 2020 | — | $0.02 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ORTI-B.ST
What is ORTI-B.ST's current stock price?
Ortivus AB (publ) (ORTI-B.ST) is currently trading at $1.21 per share. The stock has moved -0.82% today.
What is the analyst price target for ORTI-B.ST?
No analyst price targets are currently available for this stock.
What sector is Ortivus AB (publ) in?
Ortivus AB (publ) operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the STO exchange.
What is ORTI-B.ST's market cap?
Ortivus AB (publ) has a market capitalization of $0.05 billion, making it a small-cap company.
Does ORTI-B.ST pay dividends?
No, Ortivus AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACOU.ST
AcouSort AB (publ)
$2.64
Mkt Cap: $0.1B
AINO.ST
Aino Health AB (publ)
$0.18
Mkt Cap: $0.0B
EXPRS2.ST
ExpreS2ion Biotech Holding AB (publ)
$16.92
Mkt Cap: $0.0B
HEART.ST
Scandinavian Real Heart AB (Publ)
$14.00
Mkt Cap: $0.1B
LPGO.ST
Lipigon Pharmaceuticals AB (publ)
$0.01
Mkt Cap: $0.0B
MODTX.ST
Modus Therapeutics Holding AB (publ)
$0.30
Mkt Cap: $0.0B
NEWBRY.ST
Newbury Pharmaceuticals AB (publ)
$1.22
Mkt Cap: $0.0B
ONCOZ.ST
OncoZenge AB (publ)
$6.55
Mkt Cap: $0.1B
SDOS.ST
ScandiDos AB (publ)
$1.15
Mkt Cap: $0.1B
SIMRIS-B.ST
Simris Alg AB (publ)
$0.05
Mkt Cap: $0.0B
Explore stocks similar to ORTI-B.ST for comparison